Blood sugar control before surgery associated with fewer infections afterward

April 17, 2006

Patients with diabetes who have good control of blood glucose levels before having surgery may be less likely to have infections after their procedures, according to a study in the April issue of Archives of Surgery, one of the JAMA/Archives journals.

Postoperative infections, including pneumonia, wound infection, urinary tract infection and sepsis (systemic blood infection), can lead to poor outcomes and high health care costs, according to background information in the article. The risk of infection is higher in patients with diabetes. Controlling blood sugar has been shown to reduce many of the complications associated with diabetes, including kidney, nerve and eye diseases. However, previous studies have not examined whether controlling blood sugar before surgery can affect outcomes afterward.

Annika S. Dronge, M.D., Yale University School of Medicine, West Haven, Conn., and colleagues examined the relationship between glycemic (blood sugar) control and postoperative infections in 490 diabetic patients. All of the participants underwent major noncardiac surgery in the Veterans Affairs Connecticut Healthcare System between Jan. 1, 2000, and Sept. 30, 2003, and had their hemoglobin (Hb A1c) levels measured within 180 days prior to surgery. Hb A1c reflects the patient's control of blood glucose levels over the previous two to three months. Good glycemic control was defined as meeting the American Diabetes Association target, an Hb A1c level of less than 7 percent.

The patients had an average age of 71 years and 197 (40 percent) had good glycemic control. Those who did not have good glycemic control had higher rates of infectious complications after surgery, as did those who were older, had higher scores on physical status tests, had wounds that were classified as "nonclean" or had operations that took longer.

There could be two reasons for the association between glycemic control and infections, the authors write. One is that patients with better preoperative glycemic control are likely to have lower blood sugar levels after surgery as well, which has been shown in other studies to reduce risk of infection. "The other possibility for decreased postoperative infection with long-term glucose control is the overall improvement in general health and metabolic milieu of the well-controlled diabetic patient," the authors write.

"In conclusion, this study confirmed an association between tight preoperative glucose control, as indicated by Hb A1c levels less than 7 percent, and a decreased risk of postoperative infections across a spectrum of surgical cases," they conclude. "If the association is confirmed in other studies, strategies to improve glycemic control prior to elective surgery can be employed to decrease infections and improve overall outcomes for diabetic surgical patients."
(Arch Surg. 2006;141:375-380. Available pre-embargo to the media at

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to